The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease

Sebastian Paus*, Anne Grünewald, Christine Klein, Michael Knapp, Alexander Zimprich, Bernd Janetzky, Jens C. Möller, Thomas Klockgether, Ullrich Wüllner

*Corresponding author for this work
17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences